Clopidogrel: A Pharmacogenomic Perspective on its Use in Coronary Artery Disease

Abstract excerpt

The thienopyridine antiplatelet agent clopidogrel is an effective drug for the prevention of vascular events. However, data has accumulated over time to suggest it is prone to significant interpatient variability. While there are several factors that contribute to this, one of the most important is variability in forming the active metabolite necessary for clopidogrel function. Several enzymes are involved in...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Antiplatelet Therapy and Cardiovascular Diseases
• Share to Diabetes Treatment and Management
• Share to Inflammatory mediators and NSAID effects